Asgari Z - Search Results

1

Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma.

Mondello P, Derenzini E, Asgari Z, Philip J, Brea EJ, Seshan V, Hendrickson RC, de Stanchina E, Scheinberg DA, Younes A. Mondello P, et al. Among authors: asgari z. Oncotarget. 2017 Feb 21;8(8):14017-14028. doi: 10.18632/oncotarget.14876. Oncotarget. 2017. PMID: 28147336 Free PMC article.

2

Expression of CD40 ligand (CD154) in B and T lymphocytes of Hodgkin disease: potential therapeutic significance.

Clodi K, Asgari Z, Younes M, Palmer JL, Cabanillas F, Carbone A, Andreeff M, Younes A. Clodi K, et al. Among authors: asgari z. Cancer. 2002 Jan 1;94(1):1-5. doi: 10.1002/cncr.10164. Cancer. 2002. PMID: 11815953 Free article.

3

BET Inhibition-Induced GSK3β Feedback Enhances Lymphoma Vulnerability to PI3K Inhibitors.

Derenzini E, Mondello P, Erazo T, Portelinha A, Liu Y, Scallion M, Asgari Z, Philip J, Hilden P, Valli D, Rossi A, Djaballah H, Ouerfelli O, de Stanchina E, Seshan VE, Hendrickson RC, Younes A. Derenzini E, et al. Among authors: asgari z. Cell Rep. 2018 Aug 21;24(8):2155-2166. doi: 10.1016/j.celrep.2018.07.055. Cell Rep. 2018. PMID: 30134175 Free PMC article.

4

NOXA genetic amplification or pharmacologic induction primes lymphoma cells to BCL2 inhibitor-induced cell death.

Liu Y, Mondello P, Erazo T, Tannan NB, Asgari Z, de Stanchina E, Nanjangud G, Seshan VE, Wang S, Wendel HG, Younes A. Liu Y, et al. Among authors: asgari z. Proc Natl Acad Sci U S A. 2018 Nov 20;115(47):12034-12039. doi: 10.1073/pnas.1806928115. Epub 2018 Nov 7. Proc Natl Acad Sci U S A. 2018. PMID: 30404918 Free PMC article.

5

ASN007 is a selective ERK1/2 inhibitor with preferential activity against RAS-and RAF-mutant tumors.

Portelinha A, Thompson S, Smith RA, Da Silva Ferreira M, Asgari Z, Knezevic A, Seshan V, de Stanchina E, Gupta S, Denis L, Younes A, Reddy S. Portelinha A, et al. Among authors: asgari z. Cell Rep Med. 2021 Jul 21;2(7):100350. doi: 10.1016/j.xcrm.2021.100350. eCollection 2021 Jul 20. Cell Rep Med. 2021. PMID: 34337566 Free PMC article.

6

TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma.

Erazo T, Evans CM, Zakheim D, Chu EL, Refermat AY, Asgari Z, Yang X, Da Silva Ferreira M, Mehta S, Russo MV, Knezevic A, Zhang XP, Chen Z, Fennell M, Garippa R, Seshan V, de Stanchina E, Barbash O, Batlevi CL, Leslie CS, Melnick AM, Younes A, Kharas MG. Erazo T, et al. Among authors: asgari z. Nat Commun. 2022 Sep 27;13(1):5676. doi: 10.1038/s41467-022-33137-8. Nat Commun. 2022. PMID: 36167829 Free PMC article.

7

Synthetic lethality of drug-induced polyploidy and BCL-2 inhibition in lymphoma.

Portelinha A, da Silva Ferreira M, Erazo T, Jiang M, Asgari Z, de Stanchina E, Younes A, Wendel HG. Portelinha A, et al. Among authors: asgari z. Nat Commun. 2023 Mar 18;14(1):1522. doi: 10.1038/s41467-023-37216-2. Nat Commun. 2023. PMID: 36934096 Free PMC article.

8

In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma.

Mutlu AD, Cavallin LE, Vincent L, Chiozzini C, Eroles P, Duran EM, Asgari Z, Hooper AT, La Perle KM, Hilsher C, Gao SJ, Dittmer DP, Rafii S, Mesri EA. Mutlu AD, et al. Among authors: asgari z. Cancer Cell. 2007 Mar;11(3):245-58. doi: 10.1016/j.ccr.2007.01.015. Cancer Cell. 2007. PMID: 17349582 Free PMC article.

9

Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer.

Leversha MA, Han J, Asgari Z, Danila DC, Lin O, Gonzalez-Espinoza R, Anand A, Lilja H, Heller G, Fleisher M, Scher HI. Leversha MA, et al. Among authors: asgari z. Clin Cancer Res. 2009 Mar 15;15(6):2091-7. doi: 10.1158/1078-0432.CCR-08-2036. Epub 2009 Mar 10. Clin Cancer Res. 2009. PMID: 19276271 Free PMC article.

10

Th17 cell function in cancers: immunosuppressive agents or anti-tumor allies?

Anvar MT, Rashidan K, Arsam N, Rasouli-Saravani A, Yadegari H, Ahmadi A, Asgari Z, Vanan AG, Ghorbaninezhad F, Tahmasebi S. Anvar MT, et al. Among authors: asgari z. Cancer Cell Int. 2024 Oct 27;24(1):355. doi: 10.1186/s12935-024-03525-9. Cancer Cell Int. 2024. PMID: 39465401 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters